Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Eventide Asset Management, LLC's stake in Lexeo Therapeutics, Inc. fell to 3.73% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Eventide Asset Management, LLC's stake in Lexeo Therapeutics, Inc. fell to 3.73%, 1,234,834 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 3.73%
- Shares
- 1,234,834
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 3.73% | 1,234,834 |
| Finny Kuruvilla, M.D., Ph. D. | 3.73% | 1,234,834 |
| Robin C. John | 3.73% | 1,234,834 |
Source
Related
- Lexeo Therapeutics, Inc.
- Eventide Asset Management, LLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026